Roth Trades Stop-Loss For 80/20 Split: Appears Unattractive To Drug Industry
Executive Summary
Finance Committee Chairman Roth's initial approach to catastrophic coverage in a Medicare drug benefit differs substantially from the other major proposals pending on Capitol Hill.